No abstract available
MeSH terms
-
Advisory Committees / ethics*
-
Advisory Committees / organization & administration
-
Antibodies, Monoclonal / therapeutic use
-
Antineoplastic Agents / therapeutic use
-
Bioethical Issues
-
Compassionate Use Trials / ethics*
-
Compassionate Use Trials / statistics & numerical data
-
Decision Making / ethics*
-
Drug Approval
-
Drug Industry / ethics*
-
Drug Industry / statistics & numerical data
-
Guidelines as Topic
-
Humans
-
Multiple Myeloma / drug therapy
-
Patient Advocacy
-
United States
-
United States Food and Drug Administration
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
daratumumab